-
Gov’t announces £215m investment in NHS health research
pharmatimes
July 05, 2018
The government has announced an investment of £215 million to fund NHS health research aiming to “transform the lives” of millions of people living with a range of conditions.
-
Pfizer to expand venture with $600 M investment
biospectrumasia
June 07, 2018
In addition to increased funding, Pfizer will extend its leadership as a venture capital investor with an expanded team that leverages expertise across venture capital investing, business development, drug discovery and clinical development.
-
Qventus receives $30M investment to bring AI to hospital workflows
biospectrumasia
May 17, 2018
The company said in a statement that it plans to use the new money to expand its platform, which uses artificial intelligence to improve hospital workflows.
-
Thermo Fisher Scientific Announces $50 Million Investment to Enhance Biologics Capabilities
biospace
April 24, 2018
Thermo Fisher Scientific announced today that is investing $50 million in its St. Louis, Missouri site which is one of the company's Centers of Excellence (COE) for Biological Commercial Manufacturing.
-
TELA Bio Announces Series B Investment by Checkmate Capital
biospace
April 17, 2018
TELA Bio®, Inc today announced that Checkmate Capital, a strategic investment group based in Los Angeles, California and Beijing, China, has agreed to an initial Series B investment in TELA Bio.
-
Foghorn Therapeutics Launches with $50 Million
biospace
March 15, 2018
Foghorn Therapeutics, based in Cambridge, Massachusetts, was founded in 2016, but officially launched with a $50 million investment from Flagship Pioneering and associated investors.
-
Breath Biopsy company adds new investor to $15m fundraising
pharmaphorum
March 06, 2018
Owlstone Medical, the innovative company which promises to revolutionise the diagnosis of cancer by simply analysing a patient’s breath, has been given a major funding boost.
-
Takeda to add 70 jobs with €25m Dublin investment
pharmafile
March 02, 2018
Takeda has announced its investment of €25 million to construct a new “modular cell therapy facility dedicated to manufacturing a novel stem cell therapy” at Grange Castle in Dublin will create up to 70 new jobs in the process.
-
3 Biotechs That Have Doubled Investors' Money in Less Than a Year
biospace
January 24, 2018
Having a stock double in value is a good thing. Having it double—or more—in a year is even better. Keith Speights, writing for The Motley Fool, looks at three healthcare stocks that have doubled in less than 12 months.
-
What You Need to Know About Tango Therapeutics
biospace
January 17, 2018
Tango Therapeutics was officially launched in March 2017 as a cancer drug target discovery and drug development company.